Eden Research plc
EDNSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $14 | $21 | $23 | $20 |
| - Cash | $2 | $4 | $5 | $7 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $12 | $18 | $18 | $12 |
| Revenue | $1 | $2 | $2 | $2 |
| % Growth | -50.4% | 28.1% | -8% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 13% | 52.9% | 31.5% | 65.1% |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | -132.5% | -31.8% | -64.6% | -29.1% |
| Net Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -155.7% | -41% | -48.6% | -29.6% |
| EPS Diluted | -0.003 | -0.002 | -0.002 | -0.001 |
| % Growth | -31.6% | -11.8% | -30.8% | – |
| Operating Cash Flow | -$1 | $0 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$1 | $0 | -$1 | -$1 |